Malgorzata I Srebniak Selected Research

dichlorobis(azomycin)platinum II

1/2022	Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study.
1/2022	Noninvasive Prenatal Test Results Indicative of Maternal Malignancies: A Nationwide Genetic and Clinical Follow-Up Study.
1/2020	Nuchal translucency of 3.0-3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review.
1/2020	Social and medical need for whole genome high resolution NIPT.
12/2019	TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
10/2019	Placental studies elucidate discrepancies between NIPT showing a structural chromosome aberration and a differently abnormal fetal karyotype.
11/2018	Unexpected finding of uniparental disomy mosaicism in term placentas: Is it a common feature in trisomic placentas?
1/2017	The influence of SNP-based chromosomal microarray and NIPT on the diagnostic yield in 10,000 fetuses with and without fetal ultrasound anomalies.
1/2016	Cytogenetic confirmation of a positive NIPT result: evidence-based choice between chorionic villus sampling and amniocentesis depending on chromosome aberration.
1/2016	Enlarged NT (≥3.5 mm) in the first trimester - not all chromosome aberrations can be detected by NIPT.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Malgorzata I Srebniak Research Topics

Disease

10	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 01/2016
5	Aneuploidy (Aneuploid) 01/2022 - 01/2016
3	Trisomy (Trisomies) 01/2022 - 11/2018
2	Neoplasms (Cancer) 01/2022 - 04/2017
1	Lymphoma (Lymphomas) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Down Syndrome (Down's Syndrome) 01/2020
1	Uniparental Disomy 10/2019
1	Tetrasomy 05/2016
1	Trisomy 18 Syndrome 01/2016
1	Sialic Acid Storage Disease (Salla Disease) 10/2011

Drug/Important Bio-Agent (IBA)

11	dichlorobis(azomycin)platinum IIIBA 01/2022 - 01/2016
3	Cell-Free Nucleic AcidsIBA 01/2022 - 04/2017
1	N-(4-isothiocyanatophenethyl)spiperoneIBA 11/2021
1	DNA (Deoxyribonucleic Acid)IBA 04/2017
1	Genetic Markers (Genetic Marker)IBA 05/2016
1	Proteins (Proteins, Gene)FDA Link 10/2011
1	Lysosomal Membrane ProteinsIBA 10/2011